Genoox Partners With Thermo Fisher Scientific to Automate Cytogenetic Research Data Interpretation and Reporting With AI

Thermo Fisher Scientific has upgraded its leading Applied Biosystems Chromosome Analysis Suite (ChAS) software through a collaboration with Genoox, a community-driven genomic data company. ChAS users will be able to access Genoox’s cloud-based AI platform, Franklin, with the launch of CytoScan Automated Interpretation and Reporting (AIR) solution, making cytogenetic research data analysis easier.

By automating interpretation and reporting, ChAS with Franklin provides an intuitive and flexible workflow for instant access to consistent, reproducible cytogenetic analysis results. While manual interpretation can take hours, ChAS users can now get accurate results in just seconds.

Recommended AI: Eric Tippetts Announces Version 3.0 of Innovative Network Marketing App

“We developed ChAS software with input from leading cytogeneticists and continue to work with our customers to make data simpler and more intuitive,” said Chad Carter, vice president and general manager, microarrays genetic solutions, Thermo Fisher Scientific. “By collaborating with Genoox, we can make data interpretation even easier so our customers can focus on their research.”

“We are excited to partner with Thermo Fisher Scientific, a leader in cytogenetics,” said Amir Trabelsi, CEO and co-founder of Genoox. “We created Franklin to advance genomic medicine by giving users access to real world, real time genomic data. The combination of ChAS with Franklin continues this mission and we look forward to opening the platform to ChAS users.”

Recommended AI: Consider Your DOOH Buying Methods Wisely: Direct Sales vs. Programmatic Buying

[To share your insights with us, please write to sghosh@martechseries.com]